Comparison of the molecular dynamics and calculated binding free energies for nine FDA-approved HIV-1 PR drugs against subtype B and C-SA HIV PR. (Q39546443)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 November 2012

Language	Label	Description	Also known as
English	Comparison of the molecular dynamics and calculated binding free energies for nine FDA-approved HIV-1 PR drugs against subtype B and C-SA HIV PR.	scientific article published on 19 November 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23017010%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Comparison of the molecular dynamics and calculated binding free energies for nine FDA-approved HIV-1 PR drugs against subtype B and C-SA HIV PR (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23017010%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Hendrik G. Kruger

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23017010%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Thavendran Govender

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23017010%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Thirumala Govender

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23017010%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Glenn E.M. Maguire

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23017010%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Mahmoud A A Ibrahim

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23017010%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Mahmoud E. Soliman

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23017010%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Shaimaa M Ahmed

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23017010%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Yasien Sayed

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23017010%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Previn Naicker

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23017010%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

19 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23017010%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Chemical Biology and Drug Design

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23017010%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

81

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23017010%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23017010%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

208-218

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23017010%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Active-site mutations in the South african human immunodeficiency virus type 1 subtype C protease have a significant impact on clinical inhibitor binding: kinetic and thermodynamic study

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Rational approach to AIDS drug design through structural biology

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Amplification of the effects of drug resistance mutations by background polymorphisms in HIV-1 protease from African subtypes

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Synthesis and structural studies of pentacycloundecane-based HIV-1 PR inhibitors: a hybrid 2D NMR and docking/QM/MM/MD approach

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Pentacycloundecane-based inhibitors of wild-type C-South African HIV-protease

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Pentacycloundecane derived hydroxy acid peptides: a new class of irreversible non-scissile ether bridged type isoster as potential HIV-1 wild type C-SA protease inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Pentacycloundecane-diol-based HIV-1 protease inhibitors: biological screening, 2D NMR, and molecular simulation studies

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Biomolecular simulations: recent developments in force fields, simulations of enzyme catalysis, protein-ligand, protein-protein, and protein-nucleic acid noncovalent interactions

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Independent-Trajectories Thermodynamic-Integration Free-Energy Changes for Biomolecular Systems: Determinants of H5N1 Avian Influenza Virus Neuraminidase Inhibition by Peramivir

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Binding of an antiviral agent to a sensitive and a resistant human rhinovirus. Computer simulation studies with sampling of amino acid side-chain conformations. II. Calculation of free-energy differences by thermodynamic integration.

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Thermodynamic stability of water molecules in the bacteriorhodopsin proton channel: a molecular dynamics free energy perturbation study

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Computational science new horizons and relevance to pharmaceutical design

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Nonequilibrium fluctuation-dissipation theorem of Brownian dynamics

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Evaluating CASP4 predictions with physical energy functions.

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

A swift all-atom energy-based computational protocol to predict DNA-ligand binding affinity and DeltaTm.

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes.

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: mechanism for binding and drug resistance

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Rapid and accurate prediction of binding free energies for saquinavir-bound HIV-1 proteases.

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

The Protein Data Bank

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Novel binding mode of highly potent HIV-proteinase inhibitors incorporating the (R)-hydroxyethylamine isostere

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

X-ray crystallographic structure of ABT-378 (lopinavir) bound to HIV-1 protease

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Hydrophobic Core Flexibility Modulates Enzyme Activity in HIV-1 Protease

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Unique Thermodynamic Response of Tipranavir to Human Immunodeficiency Virus Type 1 Protease Drug Resistance Mutations

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

The Amber biomolecular simulation programs

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Development and testing of a general amber force field

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Free energy calculations on dimer stability of the HIV protease using molecular dynamics and a continuum solvent model

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Comparison of simple potential functions for simulating liquid water

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Overcoming drug resistance in HIV-1 chemotherapy: the binding thermodynamics of Amprenavir and TMC-126 to wild-type and drug-resistant mutants of the HIV-1 protease

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Evaluating the potency of HIV-1 protease drugs to combat resistance

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Structural and thermodynamic basis for the binding of TMC114, a next-generation human immunodeficiency virus type 1 protease inhibitor

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Computational study of protein specificity: the molecular basis of HIV-1 protease drug resistance

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Molecular Dynamics Simulations of HIV-1 Protease Suggest Different Mechanisms Contributing to Drug Resistance.

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Comparison of multiple Amber force fields and development of improved protein backbone parameters

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Binding of a diverse set of ligands to avidin and streptavidin: an accurate quantitative prediction of their relative affinities by a combination of molecular mechanics and continuum solvent models

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Estimation of serum-free 50-percent inhibitory concentrations for human immunodeficiency virus protease inhibitors lopinavir and ritonavir

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Rapid structural fluctuations of the free HIV protease flaps in solution: relationship to crystal structures and comparison with predictions of dynamics calculations

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Flap opening mechanism of HIV-1 protease

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Improved prediction of HIV-1 protease-inhibitor binding energies by molecular dynamics simulations

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

HIV-1 protease molecular dynamics of a wild-type and of the V82F/I84V mutant: possible contributions to drug resistance and a potential new target site for drugs

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Structural basis for drug and substrate specificity exhibited by FIV encoding a chimeric FIV/HIV protease

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

LigPlot+: multiple ligand-protein interaction diagrams for drug discovery

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12063

21 January 2018

Identifiers

10.1111/CBDD.12063

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23017010%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23017010%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39546443&oldid=1462521124"